Arxx Therapeutics to sponsor Scleroderma & Raynaud’s UK's (SRUK) Virtual Conference

Arxx Therapeutics is sponsoring Scleroderma & Raynaud’s UK's (SRUK) Virtual Conference September 11th 2021.

Scleroderma & Raynaud’s UK (SRUK) is the only UK Charity dedicated to improving the lives of people with scleroderma and Raynaud’s phenomenon. The Virtual Conference is lead by world leading medical experts and will be covering a whole range of information including advances in treatments, tips for self-management and new research.



Back to News

Get in touch

    We are dedicated to developing transformative therapies for patients with fibrotic disease.
    We believe that AX-202 has the potential to transform how fibrosis is treated and help many patients poorly served by current therapeutic options.
    Arxx Therapeutics
    in Norway: Gaustadalléen 21, 0349 Oslo
    in Denmark: Symbion Science Park, Fruebjergvej 3, 2100 Copenhagen 
    © 2021 Arxx Therapeutics. All rights reserved. | Privacy Policy